HIV legal precedent useful for microbial forensics

Croatian Medical Journal

Volumn 46, Issue 4, 2005, Pages 514-521

  Budowle, Bruce ^a   Harmon, Rockne ^b  

^a FBI LABORATORY   (United States)

^b Office of the District Attorney   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; BIOLOGICAL WARFARE; FORENSIC MEDICINE; HOMICIDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEGAL ASPECT; MICROBIAL FORENSICS; MICROORGANISM; MOLECULAR BIOLOGY; NONHUMAN; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; VALIDATION PROCESS;

BIOTERRORISM; CRIME; FORENSIC MEDICINE; GENETICS, MICROBIAL; HIV; HIV SEROPOSITIVITY; HUMANS; UNITED STATES;

EID: 24344453467     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, et al. Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis. 2002;8:1039-43.
2. Popović T, Glass M. Laboratory aspects of bioterrorism-related anthrax - from identification to molecular subtyping to microbial forensics. Croat Med J. 2003; 44:336-41.
3. Budowle B, Schutzer SE, Einseln A, Kelley LC, Walsh AC, Smith JA, et al. Public health. Building microbial forensics as a response to bioterrorism. Science. 2003; 301:1852-3.
4. Budowle B, Burans J, Breeze RG, Wilson MR, Chakraborty R. Microbial forensics. In: Breeze R, Budowle B, Schutzer S, editors. Microbial forensics. Amsterdam: Academic Press; 2005. p. 1-25.
5. Budowle B, Murch RS, Chakraborty R. Microbial forensics: the next forensic challenge. Int J Leg Med. In press 2005.
6. Butler JC, Cohen ML, Friedman CR, Scripp RM, Watz CG. Collaboration between public health and law enforcement: new paradigms and partnerships for bioterrorism planning and response. Emerg Infect Dis. 2002;8:1152-6.
7. Morse SA, Khan AS. Epidemiologic investigation for public health, biodefense, and forensic microbiology. In: Breeze R, Budowle B, Schutzer S, editors. Microbial forensics. Amsterdam: Academic Press; 2005. p. 157-71.
8. Treadwell TA, Koo D, Kuker K, Khan AS. Epidemiologic clues to bioterrorism. Public Health Rep. 2003;118:92-8.
9. Scientific Working Group on Microbial Genetics and Forensics. Quality assurance guidelines for laboratories performing microbial forensic work. Forensic Science Communications. 2003. Available from: http://www. fbi.gov/hq/lab/fsc/backissu/oct2003/2003_10_guide01.htm. Accessed: June 2, 2005.
10. Harmon R. Legal aspects: the standards for evidence. In: Breeze R, Budowle B, Schutzer S, editors. Microbial forensics. Amsterdam: Academic Press; 2005. p. 381-92.
11. Budowle B, Hobson DL, Smerick JB, Smith JA. Low copy number - consideration and caution. In: Twelfth International Symposium on Human Identification 2001. Madisdon (WI): Promega Corporation; Available at: http://www.promega.com/geneticidproc/ussymp12 proc/contents/budowle.pdf. Accessed: June 2, 2005.
12. Gill P. Application of low copy number DNA profiling. Croat Med J. 2001;42:229-32.
13. Gill P, Whitaker J, Flaxman C, Brown N, Buckleton J. An investigation of the rigor of interpretation rules for STRs derived from less than 100 pg of DNA. Forensic Sci Int. 2000;112:17-40.
14. Drake JW, Charlesworth B, Charlesworth D, Crow JF. Rates of spontaneous mutation. Genetics. 1998;148: 1667-86.
15. Li WH, Tanimura M, Sharp PM. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol Biol Evol. 1988;5:313-30.
16. O'Neil PK, Sun G, Yu H, Ron Y, Dougherty JP, Preston BD. Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem. 2002;277:38053-61.
17. Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science. 1988;242:1168-71.
18. Carrillo C, Rock DL. Molecular epidemiology and forensics of RNA viruses. In: Breeze R, Budowle B, Schutzer S, editors. Microbial forensics. Amsterdam: Academic Press; In press 2005.
19. Sala M, Wain-Hobson S. Are RNA viruses adapting or merely changing? J Mol Evol. 2000;51:12-20.
20. Svarovskaia ES, Cheslock SR, Zhang WH, Hu WS, Pathak VK. Retroviral mutation rates and reverse transcriptase fidelity. Front Biosci. 2003;8:d117-34.
21. Buckley M. The genomics of disease-causing organisms: mapping a strategy for discovery and defense. Washington (DC): American Academy of Microbiology; 2004.
22. McGrath S, Fitzgerald GF, van Sinderen D. The impact of bacteriophage genomics. Curr Opin Biotechnol. 2004;15:94-9.
23. Pedulla ML, Ford ME, Houtz JM, Karthikeyan T, Wadsworth C, Lewis JA, et al. Origins of highly mosaic mycobacteriophage genomes. Cell. 2003;113:171-82.
24. Keller M, Zengler K. Tapping into microbial diversity. Nat Rev Microbiol. 2004;2:141-50.
25. Rappe MS, Giovannoni SJ. The uncultured microbial majority. Annu Rev Microbiol. 2003;57:369-94.
26. Schleifer KH. Microbial diversity: facts, problems and prospects. Syst Appl Microbiol. 2004;27:3-9.
27. Gogarten JP, Doolittle WF, Lawrence JG. Prokaryotic evolution in light of gene transfer. Mol Biol Evol. 2002;19:2226-38.
28. Hacker J, Blum-Oehler G, Hochhut B, Dobrindt U. The molecular basis of infectious diseases: pathogenicity islands and other mobile genetic elements. A review. Acta Microbiol Immunol Hung. 2003;50:321-30.
29. Ochman H, Lawrence JG, Groisman EA. Lateral gene transfer and the nature of bacterial innovation. Nature. 2000;405:299-304.
30. Lake JA, Rivera MC. Deriving the genomic tree of life in the presence of horizontal gene transfer: conditioned reconstruction. Mol Biol Evol. 2004;21:681-90.
31. Brussow H, Canchaya C, Hardt WD. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev. 2004;68:560-602.
32. Canchaya C, Fournous G, Brussow H. The impact of prophages on bacterial chromosomes. Mol Microbiol. 2004;53:9-18.
33. Payne GA, Cubeta MA. Biology and detection of fungal pathogens of humans and plants. In: Breeze R, Budowle B, Schutzer S, editors. Microbial forensics. Amsterdam: Academic Press; In press 2005.
34. Marks JD. Forensic aspects of biologic toxins. In: Breeze R, Budowle B, Schutzer S, editors. Microbial forensics. Amsterdam: Academic Press; 2005. p. 131-56.
35. List of agents and toxins. Available at: http://www. cdc.gov/od/sap/docs/ salist.pdf. Accessed: June 7, 2005.
36. Ciesielski C, Marianos D, Ou CY, Dumbaugh R, Witte J, Berkelman R, et al. Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med. 1992;116:798-805.
37. Metzker ML, Mindell DP, Liu XM, Ptak RG, Gibbs RA, Hillis DM. Molecular evidence of HIV-1 transmission in a criminal case. Proc Natl Acad Sci USA. 2002;99: 14292-7.
38. Ou CY, Kwok S, Mitchell SW, Mack DH, Sninsky JJ, Krebs JW, et al. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science. 1988;239:295-7.
39. Ou CY, Ciesielski CA, Myers G, Bandea CI, Luo CC, Korber BT, et al. Molecular epidemiology of HIV transmission in a dental practice. Science. 1992;256:1165-71.
40. Robbins KE, Weidle PJ, Brown TM, Saekhou AM, Coles B, Holmberg SD, et al. Molecular analysis in support of an investigation of a cluster of HIV-1-infected women. AIDS Res Hum Retroviruses. 2002;18:1157-61.
41. Li WH, Tanimura M, Sharp PM. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol Biol Evol. 1988;5:313-30.
42. O'Neil PK, Sun G, Yu H, Ron Y, Dougherty JP, Preston BD. Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem. 2002;277:38053-61.
43. Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science. 1988;242:1168-71.
44. Hietpas J, McMullan LK, Mindell DP, Hanson HL, Rice CM. Keeping track of viruses. In: Breeze R, Budowle B, Schutzer S, editors. Microbial forensics. Amsterdam: Academic Press; In press 2005.
45. Li WH, Tanimura M, Luo CC, Datta S, Chan L. The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution. J Lipid Res. 1988;29:245-71.
46. Court of Appeal of Louisiana. Third circuit. State of Louisiana v. Richard J. Schmidt. No. K97-249. July 29, 1997.
47. Daubert v. Merrell Dow Pharmaceuticals, 509 US 579, 1999.
48. Court of Appeals of Arizona. Division 1, Department C. State of Arizona, Appellee, v. Mark Alan Bogan, Appellant. No. 1 CA-CR 93-0453. April 11, 1995.